Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Rosalba D'Alessandro

7PUBLICATIONS

23CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunologyImmunogenetics (incl. genetic immunology)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Feb 27, 2026

RETRACTED: Refolo et al. Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells. <i>Int. J. Mol. Sci.</i> 2018, <i>19</i>, 1518.

Maria Grazia Refolo, Catia Lippolis, Nicola Carella

|Apr 26, 2025

Unravelling Paclitaxel Resistance in Gastric Cancer: The Role of Small Extracellular Vesicles in Epithelial Mesenchymal Transition and Extracellular Matrix Remodelling.

Giorgia Panzetta, Annalisa Schirizzi, Francesco Balestra

|Jan 08, 2025

Circulating miR-23b-3p, miR-30e-3p, and miR-205-5p as Novel Predictive Biomarkers for Ramucirumab-Paclitaxel Therapy Outcomes in Advanced Gastric Cancer.

Emanuele Piccinno, Annalisa Schirizzi, Viviana Scalavino

|Oct 26, 2024

Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications.

Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi

|Jul 27, 2024

Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications.

Carmelo Laface, Angela Dalia Ricci, Simona Vallarelli

|Oct 28, 2023

VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment.

Annalisa Schirizzi, Aram Arshadi, Doron Tolomeo

Pageof 2

Frequent Collaborators

4 joint publications

Gianluigi Giannelli

4 joint publications

Claudio Lotesoriere

2 joint publications

Rossella Donghia

2 joint publications

Caterina Messa

2 joint publications

Alessandro Rizzo

1 joint publications

Aram Arshadi

1 joint publications

Laura Schirosi

1 joint publications

Anna Maria Valentini

1 joint publications

Clelia Tiziana Storlazzi

1 joint publications

Alfredo Zito

Frequent Collaborators

4 joint publications

Gianluigi Giannelli

4 joint publications

Claudio Lotesoriere

2 joint publications

Rossella Donghia

2 joint publications

Caterina Messa

Top Related Videos

Extended 78% Hepatectomy in a Mouse Surgical Model

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on : May 24, 2024

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on : Mar 14, 2019

See more related videos

Top Related Videos

Extended 78% Hepatectomy in a Mouse Surgical Model

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on : May 24, 2024

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on : Mar 14, 2019

See more related videos